Investor Relation
Home / Investor Relation
Financial Result
2025 – 2026
December 2025 September 2025 June 2025
2024 – 2025
March 2025 December 2024 September 2024 June 2024
2023 – 2024
March 2024 December 2023 September 2023 June 2023
2022-2023
March 2023 December 2022 September 2022 June 2022
2021-2022
March 2022 December 2021 September 2021 June 2021
2020-2021
March 2021 December 2020 September 2020 June 2020
2019-2020
March 2020 December 2019 September 2019 June 2019
2018-2019
March 2019 December 2018 September 2018 June 2018
2017-2018
March 2018 December 2017 September 2017 June 2017
2016-2017
March 2017 December 2016 September 2016 June 2016
2015-2016
March 2016 December 2015 September 2015 June 2015
2013-2014
March 2014 December 2013 September 2013 June 2013
2012-2013
Investor Information
Stock Exchange Disclosures
- Integrated Governance Report
- Notice of Board Meeting
- KYC Updation
- Open Offer
- Disclosure under Regulation 7(3) SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Disclosure under Regulation 23(9) SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- General Meeting and Postal Ballot
- Annual Secretarial Compliance Report
- Disclosure under Regulation 40(9) SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Closure of Trading Window
- Miscellaneous
- Newspaper Publications
- Familiarisation Programme
- Investors Complaint
- MOA & AOA
Shareholding Pattern
LISTING ON STOCK EXCHANGE
The BSE Limited, Mumbai, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 023.
Investor Correspondences
Any investor correspondence, regarding transfer/dematerialization of shares, dividend and any query related to the shares of the company should be addressed to:
Company Secretary And Compliance Officer
Krupali Kirti Shah
Email: info@aspiradiagnostics.com
Key Managerial Personnel For Determining Materiality Of Events
Balkrishna Talawadekar
Chief Financial Officer
Email: info@aspiradiagnostics.com
Key Managerial Personnel For Determining Materiality Of Events
Mr. Nikunj Mange
Executive Director
Email: info@aspiradiagnostics.com
Registered Office
Flat No: 2, Shah Building, Shraddhanand Road, Opp. Ghatkopar Railway Station, Ghatkopar (West), Mumbai – 400 086.
Register And Transfer Agent
MUFG Intime India Private Limited :C-101, 247 Park, LBS Marg, Vikhroli (West), Mumbai – 400 083. Fax: (022) 4918 6060
Email: Investor.helpdesk@in.mpms.mufg.com
Tel No: (022) 4918 6270
Corporate Governance
Policies
Nomination and Remuneration Policy – Aspira Pathlab
Code for Fair Disclosure and Conduct
Code of Conduct for Board Members and Senior Management Personnel
Terms and conditions of appointment of Independent Director
Policy on Determination of Materiality of Information
Policy on related party transaction
Policy for Evaluation of Performance of the Board of Directors
